Loading…
Nursing intervention to enhance outpatient chemotherapy symptom management: Patient‐reported outcomes of a randomized controlled trial
BACKGROUND The authors conducted a randomized controlled trial to evaluate a nurse practitioner (NP)‐delivered symptom management intervention for patients initiating chemotherapy for nonmetastatic cancer. The aim was to reduce patient‐reported symptom burden by facilitating patient‐NP collaboration...
Saved in:
Published in: | Cancer 2015-11, Vol.121 (21), p.3905-3913 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | BACKGROUND
The authors conducted a randomized controlled trial to evaluate a nurse practitioner (NP)‐delivered symptom management intervention for patients initiating chemotherapy for nonmetastatic cancer. The aim was to reduce patient‐reported symptom burden by facilitating patient‐NP collaboration and the early management of symptoms.
METHODS
At the time of the first chemotherapy visit, adult participants with nonmetastatic breast, colorectal, or lung cancer (120 participants) completed self‐report measures and were then randomly assigned to standard care plus the intervention or standard care alone. Intervention participants received proactive telephone calls from their oncology team NP during the week after each of the first 2 chemotherapy administration visits. Measures were repeated at the second and third chemotherapy visits. Group differences were analyzed with regard to patient‐reported symptoms (Memorial Symptom Assessment Scale‐Short Form items), satisfaction with care (Family Caregiver Satisfaction‐patient scale), and the likelihood of depression or anxiety symptoms (Patient Health Questionnaire‐4).
RESULTS
At the time of the first visit, 50.8% of participants reported ≥1 physical symptom, most commonly lack of energy (35.8%) and drowsiness (30.8%). The number of symptoms (gamma coefficient [γ] = 0.16; P |
---|---|
ISSN: | 0008-543X 1097-0142 |
DOI: | 10.1002/cncr.29585 |